The effect of 4-aminopyridine on clinical signs in multiple sclerosis: A randomized, placebo-controlled, double-blind, cross-over study-Reference-Cited by-同舟云学术

The effect of 4-aminopyridine on clinical signs in multiple sclerosis: A randomized, placebo-controlled, double-blind, cross-over study

Published:1992-08 Issue:2 Volume:32 Page:123-130
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

van Diemen Harri�t A. M.,Polman Chris H.,van Dongen Theo M. M. M.,van Loenen Arie C.,Nauta Jos J. P.,Taphoorn Martin J. B.,van Walbeek Harm K.,Koetsier Johan C.

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference22 articles.

1. Effects of 4-aminopyridine in patients with multiple sclerosis

2. 4-Aminopyridine improves clinical signs in multiple sclerosis

3. Orally administered 4-aminopyridine improves clinical signs in multiple sclerosis

4. 4-Aminopyridine in multiple sclerosis: Prolonged administration

5. Effects of 4-aminopyridine on normal and demyelinated mammalian nerve fibres

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 4-Aminopyridine is a promising treatment option for patients with gain-of-function KCNA2 -encephalopathy;Science Translational Medicine;2021-09

2. Phase IIB Randomized Trial on the Use of 4-Aminopyridine in Guillain-Barré Syndrome;Archives of Rehabilitation Research and Clinical Translation;2021-06

3. Neuroprotective Properties of 4-Aminopyridine;Neurology - Neuroimmunology Neuroinflammation;2021-03-02

4. Aminopiridines in the treatment of multiple sclerosis and other neurological disorders;Neurodegenerative Disease Management;2020-12

5. Effects of modified-release fampridine on upper limb impairment in patients with Multiple Sclerosis;Multiple Sclerosis and Related Disorders;2020-05